Ji shengli, He is the doctor,professor, chairman and general manager of ReaLi Tide Biological Technoloygy (weihai) Co.,Ltd.As a professor at Shandong University, and general manager and chief scientist of Hebei Changshan Biochemical Pharmaceutical Co., Ltd..In 2017, he was awarded the title of leading industrial talents of taishan in Shandong province.Successfully developed a series of polysaccharide drugs such as heparin, enoxaparin sodium, dheparin sodium, Nadroparin calcium, etc.Accumulated revenue reached RMB 10 billions .Lead the development of long-acting diabetes peptide drugs, is currently preparing for phase iii clinical.He undertaken more than 30 national major new drug innovation projects, national natural fund projects, international cooperation projects of the Ministry of Science and Technology, and provincial and municipal science and technology research projects.He edited and participated in the compilation of 8 works, published more than 70 papers, won 9 prizes for scientific and technological progress, and completed 6 scientific and technological achievements.In recent years, he got 11 patents, a number of core technology patents are in the process of acceptance.

　　In May 2016, he founded ReaLi Tide Biological Technology(weihai) Co.,Ltd.With a registered capital of 50 million yuan. committed to the R&D, production and sales of high-end pharmaceutical products.We invest over RMB 100 million to built a clean workshop with GMP standard,we aim to build the largest Peptide raw materials production base in north China.